Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by You-Hua Jiang
C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients With Resectable Esophageal Squamous Cell Carcinoma
Journal of Oncology
Oncology
Related publications
Prognostic Significance of C-Reactive Protein-To-Prealbumin Ratio in Patients With Esophageal Cancer
Yonago Acta Medica
Medicine
C-Reactive Protein to Albumin Ratio Is a Prognostic Factor for Patients With cStage II/III Esophageal Squamous Cell Cancer
Diseases of the Esophagus
Medicine
Gastroenterology
Nomograms Predicting Long-Term Overall Survival and Cancer-Specific Survival in Head and Neck Squamous Cell Carcinoma Patients
Oncotarget
Oncology
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients
Journal of Clinical Medicine
Prognostic Nomograms and Aggtrmmns Scoring System for Predicting Overall Survival and Cancer‐specific Survival of Patients With Kidney Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
The Value of Preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as Prognostic Factors for Long-Term Survival in Pathological T1N0 Esophageal Squamous Cell Carcinoma
Journal of Cancer
Oncology
Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pelvic Chondrosarcoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Low Preoperative Albumin-To-Globulin Ratio Predict Poor Survival and Negatively Correlated With Fibrinogen in Resectable Esophageal Squamous Cell Carcinoma
Journal of Cancer
Oncology
Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Surgically Resected Intrahepatic Cholangiocarcinoma
Cancer Management and Research
Oncology
